Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial - Ohman, E M; Roe, M T; Steg, P G (Lancet, 2017)
(10081):